Jörg Ellinger

Androgen Receptor Coactivators Lysine-Specific Histone Demethylase 1 and Four and a Half LIM Domain Protein 2 Predict Risk of Prostate Cancer Recurrence

Philip Kahl, Lucia Gullotti, Lukas C. Heukamp et al. · Cancer Research · 2006 · 463 citations

Histone Modifications, Androgen Receptor, Epigenetic Change +20

Circulating microRNAs (miRNA) in Serum of Patients With Prostate Cancer

Robert Mahn, Lukas C. Heukamp, Sebastian Rogenhofer et al. · Urology · 2011 · 241 citations

Urology, Medicine, Pathology +6

The Immune Checkpoint Regulator PD-L1 Is Highly Expressed in Aggressive Primary Prostate Cancer

Heidrun Gevensleben, Dimo Dietrich, Carsten Golletz et al. · Clinical Cancer Research · 2015 · 230 citations

MicroRNAs in Renal Cell Carcinoma: Diagnostic Implications of Serum miR-1233 Levels

Lena M. Wulfken, Rudolf Moritz, Carsten‐Henning Ohlmann et al. · PLoS ONE · 2011 · 229 citations · Full text

Global levels of histone modifications predict prostate cancer recurrence

Jörg Ellinger, Philip Kahl, Johannes von der Gathen et al. · The Prostate · 2009 · 212 citations